Pacira Pharmaceuticals Inc. (Nasdaq: PCRX) swung to a profit for the first quarter of 3 cents per share compared with a loss of 34 cents per share last year but revenue fell short of expectations sending the stock price plummeting $13.64 to close at $68.48.
Pacira Pharmaceuticals' revenue misses
April 30, 2015 at 18:59 PM EDT
